Switching from Lexapro (Escitalopram) 10mg to Prozac (Fluoxetine)
Use a cross-taper approach over 1-2 weeks: reduce escitalopram to 5mg daily while starting fluoxetine 10-20mg daily for one week, then discontinue escitalopram completely while continuing fluoxetine. 1, 2
Cross-Taper Protocol
The recommended switching strategy involves gradual cross-tapering rather than abrupt discontinuation or conservative washout periods. 3, 4
Week 1:
- Reduce escitalopram from 10mg to 5mg (50% reduction) 2
- Simultaneously start fluoxetine 10-20mg daily 1, 4
- This overlap period maintains antidepressant coverage while minimizing withdrawal risk 1
Week 2:
- Discontinue escitalopram completely 2
- Continue fluoxetine at the same dose 2
- Fluoxetine can be titrated upward after 4-6 weeks if needed for optimal response 4
Critical Safety Monitoring
Monitor intensively for serotonin syndrome during the overlap period, especially in the first 24-48 hours. 1, 2 Key symptoms include:
- Tremor, neuromuscular rigidity, hyperreflexia 1
- Agitation, confusion, mental status changes 1
- Tachycardia, hyperthermia, diaphoresis 1
- Diarrhea and sweating 2
The cross-taper approach significantly reduces discontinuation syndrome risk compared to abrupt cessation. 2 Watch for escitalopram withdrawal symptoms including:
- Dizziness, vertigo, sensory disturbances 1
- Irritability, anxiety, headache 1
- Nausea, fatigue, insomnia 1
Rationale for This Approach
Direct or rapid cross-taper switching is well-tolerated between SSRIs and does not require washout periods. 3, 4 The conservative approach with prolonged washout is unnecessary when switching between non-MAOI antidepressants and risks treatment gaps with potential symptom exacerbation. 3
Escitalopram has minimal effect on CYP450 enzymes, reducing drug interaction concerns during the overlap. 1 Fluoxetine's long half-life (4-6 days for fluoxetine, 4-16 days for its active metabolite norfluoxetine) provides built-in protection against discontinuation symptoms once established. 3
Follow-Up Schedule
Contact the patient during weeks 1-2 to assess tolerability and adherence. 2 Schedule a follow-up visit after completing the switch (week 3-4) to evaluate:
Fluoxetine typically requires 4-8 weeks at therapeutic doses before assessing full efficacy. 5, 6
Common Pitfalls to Avoid
Never abruptly discontinue escitalopram - this significantly increases discontinuation syndrome risk. 2
Do not use conservative washout periods between these SSRIs - this unnecessarily prolongs the switch and risks symptom recurrence. 3, 4
Monitor adherence closely - patients may discontinue one medication without starting the other, leading to relapse. 2
Avoid combining with MAOIs or other serotonergic agents beyond the planned cross-taper period. 2
Special Considerations
For elderly patients or those with hepatic impairment, consider:
- More gradual cross-taper over 2-3 weeks 2
- Lower starting dose of fluoxetine (10mg rather than 20mg) 2
- More frequent monitoring 2
The switch from escitalopram to fluoxetine is appropriate when seeking different pharmacologic properties within the SSRI class, such as fluoxetine's longer half-life or different side effect profile. 7, 6